Welcome to our dedicated page for Neon Bloom news (Ticker: NBCO), a resource for investors and traders seeking the latest updates and insights on Neon Bloom stock.
Neon Bloom, Inc. (OTC PINK: NBCO) issues frequent updates that outline its evolution from a life-science and cannabis-derived ingredient business toward a stronger emphasis on financial services and financial transaction processing. Its news flow highlights developments at its wholly owned subsidiary Advanced Executive Sales (AES), as well as strategic decisions such as acquisitions, divestments, and technology upgrades.
Recent announcements describe Neon Bloom’s focus on e-commerce and point-of-sale transaction solutions through AES, including the integration of an AI-driven backend software package and multi-factor authentication across its payment processing platforms. The company states that these changes are intended to reduce fraud, increase capacity, and manage vendor redundancy and charge-backs, while supporting expansion into additional areas of the fintech industry.
News items also cover Neon Bloom’s relationships with partners such as YNLO Ultratech, Payshield, Genwin LLC, and Elevated International. These relationships are described as providing back-end development software, transactional solutions, and third-party business development support in e-commerce, enterprise, and retail environments, with the goal of increasing transactional volume and yearly revenue.
Earlier releases provide context on Neon Bloom’s involvement in life-science technologies through Bazelet Health Systems Inc., including work on the patented PAN2020 cannabis plant and the PECSA ingredient, as well as the subsequent divestment of Bazelet as the company shifted its primary focus to financial services. Visitors to this news page can review a chronological archive of these corporate updates, technology implementations, partnership announcements, and strategic transactions related to NBCO.
Neon Bloom, Inc. (OTC: NBCO) announced on April 16, 2021, that Bazelet Oglesby has successfully planted its patented 0.00% THC Panakeia cannabis plants in South Georgia. This development marks Bazelet's entry into the Georgia cannabis market, utilizing a former golf course for crop production. Panakeia is the world's first patented cannabis plant with zero THC, making it compliant with federal law. Bazelet aims to provide safe and effective cannabinoid products for healthcare professionals, particularly as Georgia launches a low THC medical marijuana program.
Bazelet Health Systems, a subsidiary of Neon Bloom, Inc. (OTC: NBCO), has appointed Dr. Francisco Ward as its new Chief Medical Officer. Dr. Ward, a graduate of Johns Hopkins School of Medicine, brings over 25 years of medical expertise and leadership, particularly in the endocannabinoid system and medical cannabis. He is tasked with overseeing Bazelet's healthcare programs, clinical research, and patient experience standards from the Columbia, Maryland office. His appointment emphasizes Bazelet's commitment to effective medical treatment through advanced research and patient-centered care.
Neon Bloom, Inc. (OTC: NBCO) announces the formation of Bazelet Oglesby, LLC, a partnership with Oglesby Plants International, Inc. to develop THC/CBD-free cannabis varieties. This strategic alliance aims to advance the commercialization of cannabis for food, beverage, OTC, and pharmaceutical applications. Operated from Florida, Bazelet Oglesby boasts over $4M in recent capital improvements and a team of horticultural specialists focused on creating elite cannabis strains intended to enhance market demand for plant-derived products. This initiative positions NBCO as a leader in the sustainable cannabis industry.
Neon Bloom, Inc. (OTC: NBCO) has completed the acquisition of Bazelet Health Systems, Inc. in an all-stock deal involving 120 million shares. This acquisition positions Neon Bloom at the forefront of the cannabis industry, focusing on THC-free cannabis and genome engineering. Bazelet operates three subsidiaries: Bazelet Oglesby for plant science, Bazelet Research for CRISPR-Cas9 technologies, and Bazelet Learning for cannabis education. Co-founders Michael Clinton and David Grand emphasized the strategic importance and potential value this acquisition brings to shareholders.